Phase I Vaccine Trial Shows Promise for Preventing Triple-Negative Breast Cancer

(MedPage Today) -- At the San Antonio Breast Cancer Symposium (SABCS), investigators reported final phase I results of an alpha-lactalbumin (aLA) vaccine designed to help prevent triple-negative breast cancer (TNBC), particularly among women at...